Mersana Therapeutics Inc Long-term Investment Intensity

Latest as of December 2017: 8.0%

Mersana Therapeutics Inc long-term investment intensity. Mersana Therapeutics Inc (MRSN) has a Long-term Investment Intensity of 8.0% as of December 2017. Long-term investments of $10.48 Million represent 8.0% of total assets of $130.72 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Read MRSN total liabilities for a breakdown of total debt and financial obligations.

LT Investment Intensity

8.0%
LT Investments / Total Assets

Long-term Investments

$10.48 Million
USD

Total Assets

$130.72 Million
USD

Country

USA
NASDAQ

Long-term Investment Intensity of Mersana Therapeutics Inc (2017–2017)

Long-term investment intensity of Mersana Therapeutics Inc from 2017 to 2017. This chart shows how Mersana Therapeutics Inc's Long-term Investment Intensity has evolved across 1 annual periods from 2017 to 2017. As of December 2017, the intensity stands at 8.0%, reflecting long-term investments of $10.48 Million against total assets of $130.72 Million USD.

Mersana Therapeutics Inc Long-term Investment Intensity by Year (2017–2017)

Mersana Therapeutics Inc long-term investment intensity by year from 2017 to 2017. The table below presents the year-by-year Long-term Investment Intensity for Mersana Therapeutics Inc from 2017 to 2017, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see MRSN total assets.

Year LT Investment Intensity LT Investments (USD) Total Assets Change (pp)
2017 8.0% $10.48 Million $130.72 Million —
pp = percentage points